Oramed Pharmaceuticals
ORMP
ORMP
103 hedge funds and large institutions have $78.4M invested in Oramed Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 28 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
36% less capital invested
Capital invested by funds: $122M → $78.4M (-$43.8M)
50% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 24
Holders
103
Holding in Top 10
–
Calls
$2.38M
Puts
$928K
Top Buyers
| 1 | +$3.76M | |
| 2 | +$3.33M | |
| 3 | +$2.35M | |
| 4 |
Morgan Stanley
New York
|
+$1.79M |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$1.65M |
Top Sellers
| 1 | -$3.44M | |
| 2 | -$3.02M | |
| 3 | -$2.9M | |
| 4 |
D.E. Shaw & Co
New York
|
-$1.39M |
| 5 |
HF
HRT Financial
New York
|
-$916K |